Search

everythinglearnresearchcommunity

for

Search:↓

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

Bicalutamide is more effective and safer than spironolactone for treating female hair loss.

Clofazimine effectively treated ashy dermatosis in a patient.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Dutasteride and finasteride do not increase mood disorder risk in men with hair loss.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Both finasteride and dutasteride can cause sexual side effects, but they may differ in frequency and severity.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

A man's rash caused by Finasteride improved after stopping the drug and starting new treatments.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

New steroids were effective in blocking male hormone receptors in hamster prostates.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Simple methods using DHT levels effectively assess compliance.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.